Stockreport

Therapix Biosciences Announces Receipt of Notice of Delisting From Nasdaq and Intention to Appeal

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE  (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx
PDF TEL AVIV, Israel, Nov. 20, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical com [Read more]